In the context of application for breast cancer treatment, Bose et al. isolated 4T1 TNBC cell-derived EVs engineered to display the urokinase plasminogen activator (uPA) peptide and fused them with anti-miR-21-loaded LNPs via extrusion [201]. The gene discussed is PLAU; the disease is breast cancer.